Improved model systems for bacterial membranes from differing species: The importance of varying composition in PE/PG/cardiolipin ternary mixtures

Molecular Membrane Biology

Volumn 29, Issue 6, 2012, Pages 207-217

  Lopes, Silvia C ^a   Neves, Cristina S ^a   Eaton, Peter ^a   Gameiro, Paula ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antimicrobial; Atomic force microscopy; Bacterial membranes; Cardiolipin; Dynamic light scattering; Fluorescence anisotropy

Indexed keywords

CARDIOLIPIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL;

ANISOTROPY; ARTICLE; ATOMIC FORCE MICROSCOPY; BACTERIAL MEMBRANE; CONCENTRATION (PARAMETERS); FLUORESCENCE ANALYSIS; LIGHT SCATTERING; LIPID BILAYER; LIPID COMPOSITION; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEUS MIRABILIS; TEMPERATURE; YERSINIA; YERSINIA KRISTENSENII;

BACTERIA; CARDIOLIPINS; CELL MEMBRANE; MODELS, THEORETICAL; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLGLYCEROLS;

BACTERIA (MICROORGANISMS); PROTEUS MIRABILIS; YERSINIA KRISTENSENII;

EID: 84867080855     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687688.2012.700491     Document Type: Article

References (96)

1. Adam HJ, Laing NM, King CR, Lulashnyk B, Hoban DJ, Zhanel GG. 2009. In vitro activity of Nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates. Antimicrob Agents Chemother 53:4915-4920.
2. Arouri A, Dathe M, Blume A. 2009. Peptide induced demixing in PG/PE lipid mixtures: A mechanism for the specificity of antimicrobial peptides towards bacterial membranes?Biochim Biophys Acta 1788:650-659.
3. Basanez G, Nieva JL, Rivas E, Alonso A, Goni FM. 1996. Diacylglycerol and the promotion of lamellar-hexagonal and lamellar-isotropic phase transitions in lipids: implications for membrane fusion. Biophys J 70:2299-2306.
4. Bechinger B. 2010. Membrane association and pore formation by alpha-helical peptides. Adv Exp Med Biol 677:24-30.
5. Bechinger B, Lohner K. 2006. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim Biophys Acta 1758:1529-1539. (Pubitemid 44436087)
6. Cheng JTJ, Hale JD, Elliott M, Hancock REW, Straus SK. 2011. The importance of bacterial membrane composition in the structure and function of aurein 2.2 and selected variants. Biochim Biophys Acta 1808:622-633.
7. Chongsiriwatana NP, Patch JA, Czyzewski AM, Dohm MT, Ivankin A, Gidalevitz D, et al.2008. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci USA 105: 2794-2799. (Pubitemid 351723623)
8. Connell SD, Smith DA. 2006. The atomic force microscope as a tool for studying phase separation in lipid membranes (Review). Mol Membr Biol 23:17-28.
9. Dahlberg M, Maliniak A. 2008. Molecular dynamics simulations of cardiolipin bilayers. J Phys Chem B 112:11655-11663.
10. Degovics G, Latal A, Lohner K. 2000. X-ray studies on aqueous dispersions of dipalmitoyl phosphotidylglycerol in the presence of salt. J Appl Cryst 33:544-547. (Pubitemid 32120520)
11. Dennison SR, Morton LHG, Harris F, Phoenix DA. 2008. The impact of membrane lipid composition on antimicrobial function of an [alpha]-helical peptide. Chem Phys Lipids 151:92-102.
12. Ding J, Li P, Ho B. 2008. The Sushi peptides: Structural characterization and mode of action against Gram-negative bacteria. Cell Mol Life Sci 65:1202-1219.
13. Domènech O, Dufrêne YF, Van Bambeke F, Tukens PM, Mingeot-Leclercq M-P. 2010. Interactions of oritavancin, a new semi-synthetic lipoglycopeptide, with lipids extracted from Staphylococcus aureus. Biochim Biophys Acta 1798: 1876-1885.
14. Domènech O, Francius G, Tulkens PM, Van Bambeke F, Dufrêne Y, Mingeot-Leclercq M-P. 2009. Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: Effect on membrane permeability and nanoscale lipid membrane organization. Biochim Biophys Acta 1788:1832-1840.
15. Domènech Ò, Merino-Montero S, Montero MT, Hernández-BorrellJ. 2006. Surface planar bilayers of phospholipids used in protein membrane reconstitution: An atomic force microscopy study. Colloid Surface B 47:102-106. (Pubitemid 43111612)
16. Domènech Ò, Redondo L, Montero MT, Hernández-Borrell J. 2007a. Specific adsorption of Cytochromec on cardiolipinglycerophospholipid monolayers and bilayers. Langmuir 23:5651-5656. (Pubitemid 46826518)
17. Domènech Ò, Morros A, Cabañas ME, Montero MT, Hernández-Borrell J. 2007b. Thermal response of domains in cardiolipin content bilayers. Ultramicroscopy 107:943-947. (Pubitemid 47095103)
18. Domènech Ò, Redondo L, Picas L, Morros A, Montero MT, Hernández-Borrell J. 2007c. Atomic force microscopy characterization of supported planar bilayers that mimic the mitochondrial inner membrane. J Mol Recognit 20:546-553.
19. Epand RF, Maloy L, Ramamoorthy A, Epand RM. 2010a. Amphipathic helical cationic antimicrobial peptides promote rapid formation of crystalline states in the presence of phosphatidylglycerol: Lipid clustering in anionic membranes. Biophys J 98:2564-2573.
20. Epand RF, Maloy WL, Ramamoorthy A, Epand RM. 2010b. Probing the "charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides. Biochemistry 49: 4076-4084.
21. Epand RF, Tokarska-Schlattner M, Schlattner U, Wallimann T, Epand RM. 2007. Cardiolipin clusters and membrane domain formation induced by mitochondrial proteins. J Mol Biol 365:968-980. (Pubitemid 46014176)
22. Epand RF, Pollard JE, Wright JO, Savage PB, Epand RM. 2010c. Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins. Antimicrob Agents Chemother 54:3708-3713.
23. Epand RM, Epand RF. 2009a. Domains in bacterial membranes and the action of antimicrobial agents. Mol BioSyst 5:580-587.
24. Epand RM, Epand RF. 2009b. Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 1788:289-294.
25. Epand RM, Epand RF. 2011. Bacterial membrane lipids in the action of antimicrobial agents. J Pept Sci 17:298-305.
26. Epand RM, Rotem S, Mor A, Berno B, Epand RF. 2008. Bacterial membranes as predictors of antimicrobial potency. J Am Chem Soc 130:14346-14352.
27. Epand RF, Wang G, Berno B, Epand RM. 2009. Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37. Antimicrob Agents Chemother 53:3705-3714.
28. Esquembre R, Ferrer ML, Gutiérrez MC, Mallavia R, Mateo CR. 2007. Fluorescence study of the fluidity and cooperativity of the phase transitions of zwitterionic and anionic liposomes confined in sol-gel glasses. J Phys Chem B 111:3665-3673. (Pubitemid 46723995)
29. Findlay B, Zhanel GG, Schweizer F. 2010. Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob Agents Chemother 54:4049-4058.
30. Findlay JBC, Evans WH. 1990. Biological membranes a practical approach. Oxford: Oxford University Press.
31. Frantz J-F, Elezgaray J, Berson P, Vacher P, Dufourc EJ. 2008. Pore formation induced by an antimicrobial peptide: Electrostatic effects. Biophys J 95:5748-5756.
32. Frederix PLTM, Bosshart PD, Engel A. 2009. Atomic force microscopy of biological membranes. Biophys J 96:329-338.
33. Frias M, Benesch MGK, Lewis RNAH, McElhaney RN. 2011. On the miscibility of cardiolipin with 1,2-diacyl phosphoglycerides: Binary mixtures of dimyristoylphosphatidylethanolamine and tetramyristoylcardiolipin. Biochim Biophys Acta 1808:774-783.
34. Garidel P, Blume A. 2000. Miscibility of phosphatidylethanolamine- phosphatidylglycerol mixtures as a function of pH and acyl chain length. Eur Biophys J 28:629-638. (Pubitemid 30081909)
35. Gong Y, Ma M, Luo Y, Bong D. 2008. Functional determinants of a synthetic vesicle fusion system. J Am Chem Soc 130: 6196-6205. (Pubitemid 351657294)
36. Guentzel M. 1996. Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. Texas: University of Texas Medical Branch.
37. Gunstone FD, Harwood JL, Padley FB. 1994. The Lipid Handbook. London: Chapman and Hall/CRC.
38. Hadjicharalambous C, Sheynis T, Jelinek R, Shanahan MT, Ouellette AJ, Gizeli E. 2008. Mechanisms of alpha-defensin bactericidal action: Comparative membrane disruption by Cryptdin-4 and its disulfide-null analogue. Biochemistry 47:12626-12634.
39. Haines TH. 2009. A new look at cardiolipin. Biochim Biophys Acta 1788:1997-2002.
40. Hale JD, Hancock RE. 2007. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther 5:951-959. (Pubitemid 350303026)
41. Halling KK, Ramstedt B, Nyström JH, Slotte JP, Nyholm TKM. 2008. Cholesterol interactions with fluid-phase phospholipids: Effect on the lateral organization of the bilayer. Biophys J 95:3861-3871.
42. Hawser S, Hoban D, Bouchillon S, Badal R, Carmeli Y, HawkeyP. 2011. Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008. Eur J Clin Microbiol Infect Dis 30:173-179.
43. Hoch FL. 1992. Cardiolipins and biomembrane function. Biochim Biophys Acta 1113:71-133.
44. Huang C-H, Li S. 1999. Calorimetric and molecular mechanics studies of the thermotropic phase behavior of membrane phospholipids. Biochim Biophys Acta 1422:273-307. (Pubitemid 29512381)
45. Huang Y, Huang J, Chen Y. 2010. Alpha-helical cationic antimicrobial peptides: Relationships of structure and function. Protein Cell 1:143-152.
46. Hubner W, Mantsch HH, Kates M. 1991. Intramolecular hydrogen-bonding in cardiolipin. Biochim Biophys Acta 1066: 166-174.
47. Hurdle JG, O'Neill AJ, Chopra I, Lee RE. 2011. Targeting bacterial membrane function: An underexploited mechanism for treating persistent infections. Nat Rev Microbiol 9:62-75.
48. Lakowicz J. 1999. Principles of fluorescence spectroscopy. New York: Kluwer.
49. Leontiadou H, Mark AE, Marrink SJ. 2006. Antimicrobial peptides in action. J Am Chem Soc 128:12156-12161. (Pubitemid 44413847)
50. Lewis RNAH, McElhaney RN. 2009. The physicochemical properties of cardiolipin bilayers and cardiolipin-containing lipid membranes. Biochim Biophys Acta 1788:2069-2079.
51. Lewis RNAH, Zweytick D, Pabst G, Lohner K, McElhaney RN. 2007. Calorimetric, X-ray diffraction, and spectroscopic studies of the thermotropic phase behavior and organization of tetramyristoyl cardiolipin membranes.Biophys J. 92:3166-3177. (Pubitemid 46684577)
52. Lohner K. 2001. The role of membrane lipid composition in cell targeting of antimicrobial peptides. Norfolk: Horizon Scientific Press.
53. Lohner K. 2009. New strategies for novel antibiotics: Peptides targeting bacterial cell membranes. Gen Physiol Biophys 28:105-116.
54. Lohner K, Blondelle SE. 2005. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb Chem High Throughput Screen 8:241-256. (Pubitemid 40488604)
55. Lohner K, Latal A, Degovics G, Garidel P. 2001. Packing characteristics of a model system mimicking cytoplasmic bacterial membranes. Chem Phys Lipids 111:177-192. (Pubitemid 32702027)
56. Lohner K, Sevcsik E, Pabst G, Liu AL. 2008. Liposome-based biomembrane mimetic systems: Implications for lipid-peptide interactions. Adv Planar Lipid Bilayers Liposomes 6:103-137. (Pubitemid 351970329)
57. Lopes S, Neves C, Eaton P, Gameiro P. 2010. Cardiolipin, a key component to mimic the E. coli bacterial membrane in model systems revealed by dynamic light scattering and steady-state fluorescence anisotropy. Anal Bioanal Chem 398:1357-1366.
58. M'Baye G, Mély Y, Duportail G, Klymchenko AS. 2008. Liquid ordered and gel phases of lipid bilayers: Fluorescent probes reveal close fluidity but different hydration. Biophys J 95:1217-1225.
59. Marczak A. 2009. Fluorescence anisotropy of membrane fluidity probes in human erythrocytes incubated with anthracyclines and glutaraldehyde. Bioelectrochemistry 74:236-239.
60. Merino-Montero S, Montero MT, Hernández-Borrell J. 2006. Effects of lactose permease of Escherichia coli on the anisotropy and electrostatic surface potential of liposomes. Biophys Chem 119:101-105. (Pubitemid 43003534)
61. Michel N, Fabiano A-S, Polidori A, Jack R, Pucci B. 2006. Determination of phase transition temperatures of lipids by light scattering. Chem Phys Lipids 139:11-19. (Pubitemid 41796991)
62. Mileykovskaya E. 2007. Subcellular localization of Escherichia coli osmosensory transporter ProP: Focus on cardiolipin membrane domains. Mol Microbiol 64:1419-1422. (Pubitemid 46889911)
63. Mileykovskaya E, Dowhan W. 2009. Cardiolipin membrane domains in prokaryotes and eukaryotes. Biochim Biophys Acta 1788:2084-2091.
64. Naber KG, Hollauer K, Kirchbauer D, Witte W. 2000. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections. Int J Antimicrob Agents 16:239-243.
65. Nagamachi E, Kariyama R, Kanemasa Y. 1985. The effect of headgroup structure on phase transition of phospholipids membranes as determined by differential scanning calorimetry Physiol. Chem Phys Med NMR 17:255-260.
66. Nicolas P. 2009. Multifunctional host defense peptides: Intracellular-targeting antimicrobial peptides. FEBS J 276:6483-6496.
67. Oszlánczi Á, Bóta A, Berényi S, Klumpp E. 2010. Structural and morphological changes in bacteria-membrane mimetic DPPE/DPPG/water systems induced by sulfadiazine. Colloid Surface B 76:519-528.
68. Pathan F, Venkata D, Panguluri S. 2010. Recent patents on antimicrobial peptides. Recent Pat DNA Gene Seq 4:10-16.
69. Picas L, Montero MT, Morros A, Cabañas ME, Seantier B, Milhiet P-E, et al.2009. Calcium-induced formation of subdomains in phosphatidylethanolamine-phosphatidylglycerol bilayers: A combined DSC, 31P NMR, and AFM study. J Phys Chem B 113:4648-4655.
70. Polyansky AA, Ramaswamy R, Volynsky PE, Sbalzarini IF, Marrink SJ, Efremov RG. 2010. Antimicrobial peptides induce growth of phosphatidylglycerol domains in a model bacterial membrane. J Phys Chem Lett 1:3108-3111.
71. Pozo Navas B, Lohner K, Deutsch G, Sevcsik E, Riske KA, Dimova R, et al.2005. Composition dependence of vesicle morphology and mixing properties in a bacterial model membrane system. Biochim Biophys Acta 1716:40-48. (Pubitemid 41377148)
72. Prossnigg F, Hickel A, Pabst G, Lohner K. 2010. Packing behaviour of two predominant anionic phospholipids of bacterial cytoplasmic membranes. Biophys Chem 150: 129-135.
73. Radzishevsky IS, Rotem S, Bourdetsky D, Navon-Venezia S, Carmeli Y, Mor A. 2007. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat Biotechnol 25:657-659. (Pubitemid 46897206)
74. Rainer S, Jain MK, Ramirez F, Ioannou PV, Marecek JF, Wagner R. 1979. Phase transition characteristics of diphosphatidylglycerol (cardiolipin) and stereoisomeric phosphatidyldiacylglycerol bilayers. mono-valent and divalent metal-ion effects. Biochim Biophys Acta 558:187-198.
75. Raja M. 2010. The role of phosphatidic acid and cardiolipin in stability of the tetrameric assembly of potassium channel KcsA. J Membr Biol 234:235-240.
76. Repáková J, Holopainen JM, Morrow MR, McDonald MC, CapkováP,VattulainenI.2005. InfluenceofDPHonthe structure and dynamics of a DPPC bilayer. Biophys J 88:3398-3410. (Pubitemid 40586590)
77. Riske KA, Amaral LQ, Döbereiner HG, Lamy MT. 2004. Mesoscopic structure in the chain-melting regime of anionic phospholipid vesicles: DMPG. Biophys J 86:3722-3733. (Pubitemid 38780250)
78. Robins-Browne RM, Cianciosi S, Bordun A-M, Wauters G. 1991. Pathogenicity of Yersinia kristensenii for mice. Infect Immun 59:162-167.
79. Romantsov T, Guan Z, Wood JM. 2009. Cardiolipin and the osmotic stress responses of bacteria. Biochim Biophys Acta 1788:2092-2100.
80. Rotem S, Radzishevsky IS, Bourdetsky D, Navon-Venezia S, Carmeli Y, Mor A. 2008. Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. FASEB J 22:2652-2661.
81. Sanderson JM. 2005. Peptide-lipid interactions: insights and perspectives. Org Biomol Chem 3:201-212. (Pubitemid 40162738)
82. Sankaram MB, Powell GL, Marsh D. 1989. Effect of acyl chain composition on salt induced lamellar to inverted hexagonal phase transitions in cardiolipin. Biochim Biophys Acta 980:389-392. (Pubitemid 19224673)
83. Schlame M, Ren M. 2009. The role of cardiolipin in the structural organization of mitochondrial membranes. Biochim Biophys Acta 1788:2080-2083.
84. Seeger HM, Bortolotti CA, Alessandrini A, Facci P. 2009. Phasetransition-induced protein redistribution in lipid bilayers. J Phys Chem B 113:16654-16659.
85. Sevcsik E, Pabst G, Jilek A, Lohner K. 2007. How lipids influence the mode of action of membrane-active peptides. Biochim Biophys Acta 1768:2586-2595. (Pubitemid 47532036)
86. Sitterberg J, Gaspar MM, Ehrhardt C, Bakowsky U. 2010. Atomic force microscopy for the characterization of proteoliposomes. Methods Mol Biol 606:351-361.
87. Spyratou E, Mourelatou EA, Makropoulou M, Demetzos C. 2009. Atomic force microscopy: A tool to study the structure, dynamics and stability of liposomal drug delivery systems. Expert Opin Drug Deliv 6:305-317.
88. Stock I, Wiedemann B. 2003. Natural antimicrobial susceptibilities and biochemical profiles of Yersinia enterocolitica-like strains: Y. frederiksenii, Y. intermedia, Y. kristensenii and Y. rohdei. Immunol Med Mic 38:139-152. (Pubitemid 37297839)
89. Sulakvelidze A. 2000. Yersiniae other than Y. enterocolitica, Y. pseudotuberculosis, and Y. pestis: The ignored species. Microbes Infect 2:497-513. (Pubitemid 30387204)
90. Trevors JT. 2003. Fluorescent probes for bacterial cytoplasmic membrane research. J Biochem Biophys Methods 57: 87-103. (Pubitemid 36959826)
91. van Langen H, Schrama CA, van Ginkel G, Ranke G, Levine YK. 1989. Order and dynamics in the lamellar L alpha and in the hexagonal HII phase. Dioleoylphosphatidylethanolamine studied with angle-resolved fluorescence depolarization. Biophys J 55:937-947.
92. Weber FJ, de Bont JAM. 1996. Adaptation mechanisms of microorganisms to the toxic effects of organic solvents on membranes. Biochim Biophys Acta 1286:225-245. (Pubitemid 26426522)
93. Wydro P, Witkowska K. 2009. The interactions between phosphatidylglycerol and phosphatidylethanolamines in model bacterial membranes: The effect of the acyl chain length and saturation. Colloid Surface B 72:32-39.
94. Yeagle P. 1987. The membranes of cells. New York: Academic Press, Inc.
95. Yokota K, Kanamoto R, Kito M. 1980. Composition of cardiolipin molecular species in Escherichia coli. J Bacteriol 141:1047-1051. (Pubitemid 10076123)
96. Zhao W, Róg T, Gurtovenko AA, Vattulainen I, Karttunen M. 2008. Role of phosphatidylglycerols in the stability of bacterial membranes. Biochimie 90:930-938.